Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

268
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
268
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Disorders of Leukocytes01:27

Disorders of Leukocytes

822
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
822

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reamed and unreamed intramedullary nailing for the treatment of open and closed tibial fractures: a subgroup analysis of randomised trials.

International orthopaedics·2009
Same author

Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.

International orthopaedics·2009
Same author

[Study on evaluating sex determining region of the Y as an engrafting track of BMSCs transplantation for repairing osteonecrosis of the femoral head of rabbit].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery·2009
Same author

Positive association between benign familial infantile convulsions and LGI4.

Brain & development·2009
Same author

Catalytic enantioselective synthesis of chiral phthalides by efficient reductive cyclization of 2-acylarylcarboxylates under aqueous transfer hydrogenation conditions.

Organic letters·2009
Same author

Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease.

Internal medicine (Tokyo, Japan)·2009

Related Experiment Video

Updated: May 21, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

An update on mixed phenotype acute leukemia.

Olga K Weinberg1, Bo Zhang1, Sharon K Germans1

  • 1Division of Hematopathology, Department of Pathology, The University of Texas Southwestern Medical Center, 2230 Inwood Road, Dallas, Texas, 75235, USA.

Seminars in Diagnostic Pathology
|March 21, 2025
PubMed
Summary
This summary is machine-generated.

Mixed phenotype acute leukemias (MPALs) are rare, aggressive blood cancers. Recent classifications and molecular insights improve diagnosis and treatment strategies for these challenging leukemias.

Keywords:
Acute leukemiaDiagnosticsMixed phenotypeTherapeutics

More Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.1K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.3K

Related Experiment Videos

Last Updated: May 21, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.1K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.3K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Mixed phenotype acute leukemias (MPALs) are rare hematologic malignancies characterized by differentiation along multiple lineages.
  • MPALs represent less than 5% of acute leukemias and are associated with a poorer prognosis than standard acute lymphoblastic or myeloid leukemias.
  • Historical challenges in MPAL diagnosis and treatment stemmed from limited understanding of pathogenesis and lack of standardized classification systems.

Purpose of the Study:

  • To review updated classifications for MPAL.
  • To discuss the genomic complexity and diagnostic challenges of MPAL.
  • To outline current and emerging therapeutic strategies for MPAL.

Main Methods:

  • Review of recent literature on MPAL classifications, including WHO and ICC.
  • Analysis of studies detailing molecular and cytogenetic abnormalities in MPAL.
  • Synthesis of evidence from retrospective studies on MPAL clinical management.

Main Results:

  • New nomenclature and algorithms (EGIL, WHO, ICC) have improved MPAL definition and clinical management.
  • Recognition of diverse molecular and cytogenetic abnormalities aids classification and identifies therapeutic targets.
  • Despite advances, MPAL remains a diagnostic and therapeutic challenge due to rarity and limited cohort data.

Conclusions:

  • Updated classifications and molecular understanding are crucial for advancing MPAL diagnosis and treatment.
  • Further research, particularly on larger cohorts, is needed to overcome the diagnostic and therapeutic dilemmas posed by MPAL.
  • Targeted therapies based on genomic complexity hold promise for improving outcomes in MPAL patients.